Viking Therapeutics Inc (NASDAQ:VKTX) shares traded 21.25% higher at $73.22 on Wall Street last session.
VKTX stock price is now 16.03% away from the 50-day moving average and 25.71% away from the 200-day moving average. The market capitalization of the company currently stands at $8.11B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $80, JP Morgan recently initiated with Overweight rating for Viking Therapeutics Inc (NASDAQ: VKTX). On June 27, 2024, Morgan Stanley recently initiated its ‘Overweight’ rating on the stock quoting a target price of $105, while ‘Raymond James’ rates the stock as ‘Strong Buy’
In other news, SINGLETON J MATTHEW, Director sold 10,300 shares of the company’s stock on Sep 20 ’24. The stock was sold for $715,850 at an average price of $69.50. Upon completion of the transaction, the Director now directly owns 9,500 shares in the company, valued at $0.7 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Sep 20 ’24, President & CEO Lian Brian sold 216,130 shares of the business’s stock. A total of $15,308,553 was realized by selling the stock at an average price of $70.83. This leaves the insider owning 2,304,927 shares of the company worth $168.77 million. A total of 6.44% of the company’s stock is owned by insiders.
During the past 12 months, Viking Therapeutics Inc has had a low of $8.28 and a high of $99.41. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 36.47, and a quick ratio of 36.47. The fifty day moving average price for VKTX is $63.1029 and a two-hundred day moving average price translates $58.245224 for the stock.
The latest earnings results from Viking Therapeutics Inc (NASDAQ: VKTX) was released for 2024-09-30.
